Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 2

ash.confex.com

Oral and Poster Abstracts Oral 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Non-JAK inhibitor Therapies for Myelofibrosis Clinical Trials, Clinical Research, Diseases, Myeloid Malignancies Abdulraheem Yacoub, MD1*, Mrinal M. Patnaik, MBBS2, Haris Ali, MD3, Eunice S. Wang, MD4, Vikas Gupta, MD, FRCP, FRCPath5, Sangmin Lee,...

  • Tagraxofusp in Relapsed/Refractory Myelofibrosis after JAK Inhibitor Therapy (from #ASH21)